Skip to content
healthcare.dev

ERIBULIN MESYLATE

NDC 40033-364, eribulin mesylate, injection, from Kindos Pharmaceuticals Co., Ltd..

Product NDC
40033-364
Status
Listed
Labeler
Kindos Pharmaceuticals Co., Ltd.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218142
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/40033-364 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERIBULIN MESYLATE.5 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
40033-364-01400330364011 VIAL, SINGLE-DOSE in 1 CARTON (40033-364-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9bfd8ac7-57e2-4c9d-add8-26502cfb54a8

Use it

Look up 40033-364 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/40033-364 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 40033-364. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.